23andMe receives court approval for sale to TTAM Research Institute
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 30 2025
0mins
Bankruptcy Court Approval: 23andMe Holding has received approval from the U.S. Bankruptcy Court to sell most of its assets and operations to TTAM Research Institute, led by co-founder Anne Wojcicki, for $305 million.
Transaction Details: The sale includes key business lines such as the Personal Genome Service and Lemonaid Health, with the transaction expected to close in the coming weeks, pending customary conditions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
